Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study

Radiotherapy and Oncology

Volumn 103, Issue 3, 2012, Pages 305-313

  Charra Brunaud, Claire ^a   Harter, Valentin ^a   Delannes, Martine ^g   Haie Meder, Christine ^c   Quetin, Philippe ^d   Kerr, Christine ^e   Castelain, Bernard ^f   Thomas, Laurence ^b   Peiffert, Didier ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

^b INSTITUT BERGONIÉ   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Bon Secours Hospital   (France)

^e CENTRE VAL D AURELLE   (France)

^f CENTRE OSCAR LAMBRET   (France)

^g INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Cervical cancer; Image guided brachytherapy; Pulsed dose rate

Indexed keywords

ANTINEOPLASTIC AGENT; CESIUM; CISPLATIN; IRIDIUM;

ADENOCARCINOMA; AGE; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; FRANCE; GASTROINTESTINAL TOXICITY; GYNECOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOGRAPHY; RADIOISOTOPE THERAPY; RECURRENCE FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; URINARY TRACT DISEASE; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MIDDLE AGED; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; UTERINE CERVICAL NEOPLASMS;

EID: 84861807198     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.04.007     Document Type: Article

References (66)

1. M.D. Logsdon, and P. Eifel Figo III B squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing balance between external beam and intracavity radiation therapy Int J Radiat Oncol Biol Phys. 43 1999 763 775
2. J. Fowler, and M. Mount Pulsed brachytherapy: the conditions for no significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy Int J Radiat Oncol Biol Phys 23 1992 661 669
3. B.D.K. Bachtiary, and M. Pintilie Comparison of late toxicity between continuous low dose rate and pulsed dose rate brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 63 2005 1077 1082
4. E. Briot, R. de Crevoisier, P. Petrow, and C. Haie-Meder Dose volume histogram analysis for tumour and critical organs in intracavitary brachytherapy of cervical cancer with the use of MRI Radiother Oncol 60 2001 S3
5. C. Fellner, R. Pötter, and T.H. Knocke Comparison of radiograph and computed tomography based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects Radiother Oncol 58 2001 53 62
6. C. Kirisits, R. Pötter, S. Lang, J. Dimopoulos, N. Wachter-Gerstner, and D. Georg Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer Int J Radiat Oncol Biol Phys 62 2005 901 911
7. A.A. Tardivon, K. Kinkel, E. Lartigau, J. Masselot, A. Gerbaulet, and D. Vanel MR imaging during intracavitary brachytherapy of vaginal and cervical cancer: preliminary results Radiographics 16 1996 1363 1370
8. N. Wachter-Gerstner, S. Wachter, E. Reinstadler, C. Fellner, T.H. Knocke, and R. Pötter The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial Radiother Oncol 68 2003 51 59
9. C. Haie-Meder, R. Pötter, E. van Limbergen, E. Briot, and M. de Brabandere JCA D. Recommendations for Gynaecological (GYN) GEC ESTRO Working Group (I): concepts and terms in 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245
10. R. Pötter, C. Haie-Meder, E. van Limbergen, I. Barillot, M. de Brabandere, and J. Dimopoulos Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy- 3D dose volume parameters ans aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
11. R. Remonnay, M. Morelle, P. Pommier, C. Haie-Meder, P. Quetin, and C. Kerr Evaluation économique de la curiethérapie de débit pulsé gynécologique (PDR) avec optimisation de la dose pour les cancers du col utérin Cancer Radiother 14 2010 161 168
12. Y. Métayer, P. Meyer, C. Brunaud, and D. Peiffert Contrôle de qualité en curiethérapie de débit de dose pulsé Cancer Radiother 13 2009 318 322
13. R.G. Dale The application of the linear-quadratic dose effect equation to fractionated and protracted radiotherapy Br J Radiol 58 1985 515 529
14. S. Lang, A. Nulens, E. Briot, C. Kirisits, and M. de Brabandere I. D. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC ESTRO recommendations Radiother Oncol 78 2006 185 193
15. P. Sminia, C.J. Schneider, and K. Koedooder Pulse frequency in pulsed brachytherapy based on tissue repair kinetics Int J Radiat Oncol Biol Phys 41 1998 139 150
16. J.B. van de Kamer, A.A.C. De Leeuw, M.A. Moerland, and I.M. Jürgenliemk-Schulz Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer Radiother Oncol 94 2010 248 253
17. A. Trotti, and A.D. Colevas Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
18. D. Schoenfeld, and J. Richter Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint Biometrics 38 1982 163 170
19. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
20. D.R. Cox Regression model and life tables (with discussion) J R Stat Soc 34 1972 187 220
21. R. Pötter, J. Dimopoulos, P. Georg, S. Lang, C. Waldhaüsl, and N. Wachter-Gerstner Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155
22. R. Pötter, P. Georg, J.C. Dimopoulos, M. Grimm, D. Berger, and N. Nesvacil Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer Radiother Oncol 100 2011 116 123
23. C. Haie-Meder, F.A. Siebert, and R. Pötter Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy Radiother Oncol 100 2011 333 343
24. W. Decker, B. Erickson, K. Albano, and M. Gillin Comparison of traditional low-dose-rate to optimized and non optimized high dose rate tandem and ovoid dosimetry Int J Radiat Oncol Biol Phys 50 2001 561 567
25. J. Mai, J. Rownd, and B. Erickson CT-guided high dose rate dose prescription for cervical carcinoma: the importance of uterine wall thickness Brachytherapy 1 2002 27 35
26. R.S. Malyapa, S. Mutic, D.A. Low, I. Zoberi, W.R. Bosch, and R. Laforest Physiologic FDG-PET three dimensional brachytherapy treatment planning for cervical cancer Int J Radiat Oncol Biol Phys 54 2002 1140 1146
27. R. Pötter, T.H. Knocke, C. Fellner, M. Baldass, A. Reinthaller, and H. Kucera Definitive radiotherapy based on HDR brachytherapy with Iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations Cancer Radiother 4 2000 159 172
28. L. Poupon, B. Castelain, and E. Lartigau Pulse dose rate brachytherapy: optimization and place of imaging Cancer Radiother 7 2003 136 146
29. L.M. Sun, E.Y. Huang, S.F. Ko, C.J. Wang, S.W. Leung, and H. Lin Computer tomography-assisted three dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer Radiother Oncol 71 2004 333 337
30. A.N. Viswanathan, J. Dimopoulos, and C. Kirisits Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours Int J Radiat Oncol Biol Phys 68 2007 491 498
31. J.C. Lindegaard, K. Tanderup, S.K. Nielsen, S. Haack, and J. Gelineck MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 71 2008 756 764
32. C. Chargari, N. Magné, I. Dumas, T. Messai, L. Vicenzi, and N. Gillion Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 74 2009 133 139
33. K. Tanderup, S.K. Nielsen, G.B. Nyvang, E.M. Pedersen, L. Rohl, and T. Aagaard From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Radiother Oncol 94 2010 173 180
34. M. de Brabandere, A.G. Mousa, A. Nulens, A. Swinnen, and E. van Limbergen Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma Radiother Oncol 88 2008 217 226
35. I.M. Jürgenliemk-Schulz, R.J. Tersteeg, J.M. Roesink, S. Bijmolt, C.N. Nomden, and M.A. Moerland MRI-guided treatment planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer Cancer Radiother 93 2009 322 330
36. C. Haie-Meder, C. Chargari, A. Rey, I. Dumas, P. Morice, and N. Magné MRI-based low dose rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy Radiother Oncol 96 2010 161 165
37. D. Chassagne, A. Gerbaulet, and J.M. Cosset Intérêt diagnostique de l'empreinte vaginale dans le cancer de l'utérus J Radiol Electrol 60 1979 375 378
38. G. Delouche, and F. Milhaud Col de l'utérus: méthode de Saint-Cloud B. Pierquin, G. Marinello, A practical manual of brachytherapy 1997 Medical PHysics Publishing Madison
39. D. Bodurka-Bevers, M. Morris, P.J. Eifel, C. Levenback, M.W. Bevers, and K.R. Lucas Post therapy surveillance of women with cervical cancer: an outcomes analysis Gynecol Oncol 78 2000 187 193
40. C. Haie-Meder, C. Chargari, A. Rey, I. Dumas, P. Morice, and N. Magné DVH parameters and outcome for patients with eartly stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery Radiother Oncol 93 2009 316 321
41. C.A. Perez, P.E. Grigsby, M.A. Lockett, K.S. Chao, and J. Williamson Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation Int J Radiat Oncol Biol Phys 44 1999 855 866
42. J. Dimopoulos, V. De Vos, and D. Berger Al e. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations Radiother Oncol 91 2009 166 172
43. M.P. Schmid, C. Kirisits, N. Nesvacil, J. Dimopoulos, D. Berger, and R. Pötter Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis Radiother Oncol 100 2011 468 472
44. T. Toita, S. Kato, Y. Niibe, T. Ohno, T. Kazumoto, and T. Kodaira Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4 cm) stage I and II uterine cervical cancer Int J Radiat Oncol Biol Phys 82 2012 49 56
45. J.A. Green, J.M. Kirwan, J.F. Tirney, P. Symonds, L. Fresco, and M. Collingwood Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis Lancet 358 2001 781 786
46. I. Barillot, J.C. Horiot, P. Maingon, M.C. Bone-Lepinoy, D. Vaillant, and S. Feutray Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy Radiother Oncol 30 1994 231 238
47. R.Y. Kim, and S. Shen J D. Image based three dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose volume histograms of the bladder, rectum, sigmoid colon, and small bowell Brachytherapy 6 2007 187 194
48. P. Georg, S. Lang, J.C.A. Dimopoulos, W. Dörr, A. Sturdza, and D. Berger Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy Int J Radiat Oncol Biol Phys 79 2011 356 362
49. F.D. Patel, P. Kumar, G. Karunanidhi, S.C. Sharma, and R. Kapoor Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix Brachytherapy 10 2011 147 153
50. J.C. Cheng, L.C. Peng, Y.H. Chen, D.Y. Huang, J.K. Wu, and J.J. Jian Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high dose rate intracavitary brachytherapy Int J Radiat Oncol Biol Phys 57 2003 1010 1018
51. F. van den Bergh, H. Meertens, L. Moonen, B. van Bunningen, and A. Blom The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix Radiother Oncol 47 1998 85 90
52. A.M. Olszewska, A.E. Saarnack, R.W. de Boer, B. van Bunningen, and M.J. Steggerda Comparison of dose volume histograms and dose wall histograms of the rectum of patients treated with intracavitary brachytherapy Radiother Oncol 61 2001 83 85
53. N. Wachter-Gerstner, S. Wachter, E. Reinstadler, C. Fellner, T.H. Knocke, and A. Wambersie Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume-histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point Radiother Oncol 68 2003 269 276
54. K.T. Hyun, J. Choi, S.Y. Park, S.H. Lee, K.C. Lee, and D.S. Yang Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma Cancer 104 2005 1304 1311
55. L. Rogers, J.H. Freel, and L.B. Speiser Pulsed-dose-rate brachytherapy for uterine cervix carcinoma Int J Radiat Oncol Biol Phys 43 1999 95 100
56. P.S. Swift, P. Purser, L.W. Roberts, B. Pickett, C.B. Powell, and T.L. Phillips Pulsed low dose rate brachytherapy for pelvic malignancies Int J Radiat Oncol Biol Phys 37 1997 811 817
57. G. Rath, D.N. Sharma, P.K. Julka, V. Subramani, A.I. Bah, and K.P. Haresh Pulsed dose rate intracavitary brachytherapy for cervical carcinoma. The AIIMS experience Am J Clin Oncol 33 2010 238 241
58. S. Kato, D.N.L. Tran, T. Ohno, T. Nakano, H. Kiyohara, and Y. Ohkubo CT-based 3D Dose-Volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with High-Dose-Rate intracavitary brachytherapy J Radiat Res 51 2010 215 221
59. H.C. Kang, K.H. Shin, S.Y. Park, and J.Y. Kim 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control Radiother Oncol 97 2010 507 513
60. E.F. Fidarova, D. Berger, S. Schüssler, J. Dimopoulos, C. Kirisits, and P. Georg Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses Radiother Oncol 97 2010 76 79
61. H.M. Keys, B.N. Bundy, F.B. Stehman, T. Okagaki, D.G. Gallup, and A.F. Burnett Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group Gynecol Oncol 89 2003 343 353
62. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, and P. Perego Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer Lancet 350 1997 535 540
63. P. Lèguevaque, S. Motton, M. Delannes, D. Querleu, M. Soulé-Tholy, and G. Tap Completion Surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer? Eur J Obstet Gynecol Reprod Biol 155 2011 188 192
64. C.A. Perez, and M.S. Kao Radiation Therapy alone or combined with surgery in the treatment of barrel-shaped carcinoma of the uterine cervix (stage IB, IIA, IIB) Int J Radiat Oncol Biol Phys 11 1985 1903 1909
65. C. Touboul, C. Uzan, A. Mauguen, S. Gouy, A. Rey, and P. Pautier Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy ofr locally advanced cervical cancer Gynécologie Obstétrique et Fertilité 39 2011 274 280
66. D.H. Weems, W.M. Mendenhall, F.J. Bova, R.B. Marcus, L.S. Morgan, and R.R. Million Carcinoma of the intact uterine cervix, stage IB-IIA-B, >= 6 cm in diameter: irradiation alone vs preoperative irradiation and surgery Int J Radiat Oncol Biol Phys 11 1985 1911 1914